Restarting Wegovy After a 3-Week Break: What Actually Happens

The myth: pick up where you left off

The most common misconception after a three-week break is that you can simply inject the next dose in your usual sequence and carry on. It feels logical, you were doing fine before you stopped, so why not continue at the same strength? The reality is that your body's tolerance to semaglutide builds gradually during titration and fades during a break. A three-week gap is long enough for a meaningful drop in circulating drug levels, because semaglutide has a half-life of roughly seven days. By week three of no injections, most of what was in your system has cleared.

That matters because the nausea, vomiting and digestive discomfort that semaglutide can cause are most pronounced when the drug concentration rises quickly relative to what your gut has adapted to. Jumping straight back to, say, 1.7 mg or 2.4 mg after three weeks off could feel a lot like your first week on the medicine, or worse. Stepping down first is not a setback; it's the clinically sensible way to protect your comfort and keep you on the treatment long term. The NHS semaglutide medicines page notes that restarting after a missed period is something to discuss with your prescriber or pharmacist rather than self-manage.

What a three-week break actually does to your dose schedule

A break of this specific length sits in a clinically awkward middle ground. It's longer than the one or two weeks where many prescribers feel comfortable resuming at the same dose, and shorter than the gaps of six weeks or more where a full return to the starting 0.25 mg is almost always advised. For a three-week gap, the most common guidance is to step back one or two dose levels, but the precise decision belongs to your prescriber, who will weigh your previous highest tolerated dose, how long you were on it before stopping, and whether the reason for stopping (illness, supply issues, surgery, something else) has any bearing on your current health.

It's worth being honest with your prescriber about why the break happened. If you stopped because side effects were difficult, that context should shape the restart plan, perhaps a slower titration the second time, or practical tips on eating patterns and meal sizes that make the adjustment easier. If you'd like to understand how a shorter two-week break is typically handled, that comparison can help you see why the advice shifts as the gap lengthens. You can also read about the clinical profile of semaglutide to understand what happens in the body during and after a pause.

One thing that doesn't change: you'll still need a valid prescription. Every re-supply through a regulated pharmacy requires clinical review; a three-week gap makes that review particularly relevant. The where to buy Wegovy guide covers what to look for in a legitimate UK prescribing service.

Side effects to watch for when you restart

Restarting at a lower dose should reduce the likelihood of a difficult return, but it doesn't guarantee a smooth ride. The most frequently reported effects when resuming semaglutide are nausea, loose stools, constipation, and a feeling of fullness that comes on quickly during meals. These tend to be most noticeable in the first few days after each injection and usually ease as the week progresses. Eating smaller portions, choosing lower-fat foods during the readjustment period, and staying well hydrated all help.

More serious symptoms require prompt medical attention. Severe stomach pain that doesn't pass (particularly if it radiates towards the back) should be assessed urgently, as it can be a sign of pancreatitis, a rare but serious side effect that the MHRA has specifically highlighted in its guidance on GLP-1 medicines. You can report any suspected side effect through the MHRA's Yellow Card scheme, which also accepts reports from patients (not just healthcare professionals). If you're unsure whether a symptom is serious, contact your prescribing service's aftercare team or NHS 111.

Many people find that the second time through titration is easier than the first, partly because they know what to expect, and partly because the body isn't entirely naive to the medicine. That's a realistic expectation, not a guarantee. Everyone's experience differs.

Planning a sustainable restart with clinical support

The practicalities matter. Getting your restart right is partly about the dose and partly about having someone to call if things feel off. This is one of the reasons clinical aftercare carries real weight for a prescription medicine like this, not as a marketing point, but as a functional part of safe treatment. If you've been off Wegovy for three weeks and are thinking about resuming, a structured consultation is the natural next step rather than guessing at the right dose alone.

If your break has stretched or may stretch further, it's useful to know that the clinical approach shifts again at longer intervals. Gaps of a month or more follow a slightly different path; you can read about the considerations around restarting after one month off or, for a substantially longer pause, what to expect after three months. The weight management treatment overview is a good place to get a broader sense of how Wegovy fits alongside other approaches. If questions about costs are part of the picture, the treatment options page shows what's included in a private prescription service transparently.

Starting your free consultation connects you with a GPhC-registered prescriber who can review your history and confirm the right restart dose for your specific situation, including whether Wegovy remains the most appropriate treatment at this point.